Catalyst Pharmaceuticals, Inc. (DELISTED) (CPRX:DL)
31.49
0.00 (0.00%)
USD |
NASDAQ |
Jul 24, 16:00
Catalyst Pharmaceuticals Gross Profit Margin (Quarterly) : 83.82% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 83.82% |
| December 31, 2025 | 76.71% |
| September 30, 2025 | 78.44% |
| June 30, 2025 | 79.56% |
| March 31, 2025 | 80.73% |
| December 31, 2024 | 78.15% |
| September 30, 2024 | 77.76% |
| June 30, 2024 | 79.83% |
| March 31, 2024 | 77.81% |
| December 31, 2023 | 77.51% |
| September 30, 2023 | 77.94% |
| June 30, 2023 | 79.38% |
| March 31, 2023 | 80.70% |
| December 31, 2022 | 81.57% |
| September 30, 2022 | 83.12% |
| Date | Value |
|---|---|
| June 30, 2022 | 85.61% |
| March 31, 2022 | 86.33% |
| December 31, 2021 | 80.82% |
| September 30, 2021 | 85.23% |
| June 30, 2021 | 87.50% |
| March 31, 2021 | 84.50% |
| December 31, 2020 | 84.30% |
| September 30, 2020 | 86.77% |
| June 30, 2020 | 86.02% |
| March 31, 2020 | 85.75% |
| December 31, 2019 | 85.40% |
| September 30, 2019 | 85.80% |
| June 30, 2019 | 85.20% |
| March 31, 2019 | 86.14% |
| December 31, 2018 | 97.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -- |
| Indivior Pharmaceuticals, Inc. | 85.42% |
| Exelixis, Inc. | 96.71% |
| United Therapeutics Corp. | 87.30% |
| Krystal Biotech, Inc. | 93.46% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 24.39% |
| Return on Assets | 21.34% |
| Return on Invested Capital | 24.31% |
| Profit Margin (Quarterly) | 42.66% |
| Operating Margin (Quarterly) | 49.02% |
| Return on Net Operating Assets | 78.37% |